 |
|
|
| |
Ledipasvir/Sofosbuvir for 12 Weeks Is Safe and Effective in Patients with Chronic Hepatitis C and Hepatitis B Coinfection: A Phase 3 Study in Taiwan
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-22 Amsterdam Netherlands
Chun-Jen Liu,1 Wan-Long Chuang,2 I-Shyan Sheen,3 Horng-Yuan Wang,4 Chi-Yi Chen,5 Kuo-Chih Tseng,6 Ting-Tsung Chang,7 Benedetta Massetto,8 Jenny C. Yang,8 Gregory Camus,8 Deyuan Jiang,8 Steven J. Knox,8 Diana M. Brainard,8 John G. McHutchison,8 Tsung-Hui Hu,9 You-Chun Hsu,10 Gin-Ho Lo,11 Chi-Jen Chu,12 Jyh-Jou Chen,13 Cheng-Yuan Peng,14 Ron-Nan Chien,15 Pei-Jer Chen16
1Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan; 2Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 3Chang Gung Memorial Hospital, Taoyuan, Taiwan; 4Mackay Memorial Hospital, Taipei; 5Chia-Yi Christian Hospital, Chia-Yi, Taiwan; 6Dalin Tzu Chi Hospital, Chia-Yi; 7National Cheng Kung University Hospital, Tainan, Taiwan; 8Gilead Sciences, Inc., Foster City, California, USA; 9Chang Gung Memorial Hospital, Kaohsiung; 10Changhua Christian Hospital, Changhua, Taiwan; 11E-DA Hospital, Kaohsiung; 12Taipei Veterans General Hospital, Taipei; 13Chi Mei Hospital, Tainan; 14China Medical University Hospital, Taichung, Taiwan; 15Chang Gung Memorial Hospital, Keelung, Taiwan; 16National Taiwan University College of Medicine and Hospital, Taipei, Taiwan
|
| |
|
|
|
|
|
